Working to provide information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF)
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits.
Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Results showed that the majority of patients surveyed, who are currently on a vitamin K antagonist such as warfarin, agreed that patient self-monitoring (PSM) would give 79% of them, who would prefer to live a life free from frequent clinic visits, the option to do so. AF or ‘atrial fibrillation’ is the most common heart rhythm disorder, and is a leading cause of AF-related stroke. AF is responsible for 20% of all strokes; for individuals with AF, the risk of suffering an AF-related stroke is increased by nearly 500%.
Click here to view press release for this survey
Click here to download results for this survey